Tradestie Institutional Equity Comparison Engine
SGHT vs WOK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SGHT Overall Edge
SGHT Captures Institutional Edge (3โ0 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sight Sciences, Inc. Common Stock (SGHT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SGHT trades at N/M Forward P/E with -20.2% operating margin (+25.2% YoY revenue) versus WOK at N/M Forward P/E and -41.7% operating margin (+19.1% YoY). In options structure, SGHT sits in BREAKOUT (8th %ile IV; Dealer Gamma Walls on Pro) against WOK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SGHT N/M vs WOK N/M Fwd P/E
Growth & Margin Winner
SGHT
Op Margin -20.2% vs -41.7% ยท YoY +25.2% vs +19.1%
Momentum & Technical Winner
SGHT
1Y +50.2% vs -72.0% ยท 52W Pos 88% vs 16%
Options & Structure Winner
SGHT
BREAKOUT (8th %ile IV) vs UNCLASSIFIED (N/A IV)
SGHT
NASDAQ
Sight Sciences, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$10.59
-2.22% 1D
Market Cap
$601.9M
1M Return
+27.9%
1Y Return
+50.21%
Forward P/E
N/M
Unified AI Score
35.1 / 100
SELL
Tech 50.0
Fund 32.0
Flow 57.0
Mom 50.0
WOK
NASDAQ
WORK Medical Technology Group LTD Class A Ordinary Shares
Surgical & Medical Instruments & Apparatus
$1.23
+2.5% 1D
Market Cap
$5.4M
1M Return
+12.84%
1Y Return
-72.05%
Forward P/E
N/M
Unified AI Score
25.6 / 100
SELL
Tech 5.0
Fund 39.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SGHT +50.21%
WOK -72.05%
Spread: +122.26 pp (SGHT Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SGHT TTM Op. Margin: -20.2%
WOK TTM Op. Margin: -41.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SGHT vs WOK. Trailing 12-month operating profitability (SGHT -20.2% vs WOK -41.7%) and valuation multiples (SGHT N/M vs WOK N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SGHT | WOK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $601.9M | $5.4M | Larger Scale | SGHT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +25.2% | +19.1% | Higher Growth | SGHT |
| Operating Margin (TTM) Profitability | -20.2% | -41.7% | Higher Margin | SGHT |
| Net Profit Margin Profitability | -32.1% | -41.9% | Higher Margin | SGHT |
| Return on Equity (ROE) Capital Efficiency | -50.1% | -19.2% | Higher ROE | WOK |
| 52-Week Range Position Momentum | 88% ($3โ$12) | 16% ($0โ$7) | Stronger Trend | SGHT |
| Beta / 30D Volatility Risk Regime | 1.05ฮฒ ยท 45% Vol | 38.49ฮฒ ยท 153% Vol | Lower Realized Risk | SGHT |
| Unified Institutional Score Composite Signal | 35.1 / 100 (SELL) | 25.6 / 100 (SELL) | Higher Composite | SGHT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SGHT vs WOK Buy Guide
SGHT
BREAKOUT
33d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
WOK
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SGHT nor WOK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.